Year |
Citation |
Score |
2022 |
Imran A, Shehzad MT, Shah SJA, Laws M, Al-Adhami T, Rahman KM, Khan IA, Shafiq Z, Iqbal J. Development, Molecular Docking, and ADME Evaluation of Selective ALR2 Inhibitors for the Treatment of Diabetic Complications Suppression of the Polyol Pathway. Acs Omega. 7: 26425-26436. PMID 35936488 DOI: 10.1021/acsomega.2c02326 |
0.671 |
|
2022 |
Imran A, Shehzad MT, Shah SJA, Al Adhami T, Laws M, Rahman KM, Alharthy RD, Khan IA, Shafiq Z, Iqbal J. Development and exploration of novel substituted thiosemicarbazones as inhibitors of aldose reductase via in vitro analysis and computational study. Scientific Reports. 12: 5734. PMID 35388067 DOI: 10.1038/s41598-022-09658-z |
0.676 |
|
2021 |
Baah S, Laws M, Rahman KM. Antibody-Drug Conjugates-A Tutorial Review. Molecules (Basel, Switzerland). 26. PMID 34063364 DOI: 10.3390/molecules26102943 |
0.647 |
|
2021 |
Laws M, Jin P, Rahman KM. Efflux pumps in Mycobacterium tuberculosis and their inhibition to tackle antimicrobial resistance. Trends in Microbiology. PMID 34052094 DOI: 10.1016/j.tim.2021.05.001 |
0.598 |
|
2020 |
Laws M, Hind C, Rahman KM, Sutton JM, Wand ME. Whole Genome Sequencing of Staphylococcus aureus SA-1199B Reveals Previously Unreported Mutations. International Journal of Antimicrobial Agents. 106225. PMID 33189889 DOI: 10.1016/j.ijantimicag.2020.106225 |
0.493 |
|
2020 |
Laws M, Surani YM, Hasan MM, Chen Y, Jin P, AlAdhami T, Chowdhury M, Imran A, Psaltis I, Jamshidi S, Nahar KS, Rahman KM. Current Trends and Future Approaches in Small-Molecule Therapeutics for COVID-19. Current Medicinal Chemistry. PMID 32693756 DOI: 10.2174/0929867327666200721161840 |
0.476 |
|
2020 |
Laws M, Hind C, Favaron A, Jamshidi S, Evans B, Clifford M, Sutton JM, Rahman KM. N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria. Acs Omega. 5: 11923-11934. PMID 32548371 DOI: 10.1021/acsomega.9b03910 |
0.605 |
|
2019 |
Picconi P, Jeeves R, Moon CW, Jamshidi S, Nahar KS, Laws M, Bacon J, Rahman KM. Noncytotoxic Pyrrolobenzodiazepine-Ciprofloxacin Conjugate with Activity against . Acs Omega. 4: 20873-20881. PMID 31867477 DOI: 10.1021/acsomega.9b00834 |
0.667 |
|
2019 |
Laws M, Shaaban A, Rahman KM. Antibiotic Resistance Breakers: Current Approaches and Future Directions. Fems Microbiology Reviews. PMID 31150547 DOI: 10.1093/femsre/fuz014 |
0.615 |
|
Show low-probability matches. |